Ticker LaunchReverse merger · Completed · CBLI
Cytocom Inc.
Reverse merger with Cleveland BioLabs, Inc. (CBLI)
Cytocom Inc. merged into Cleveland BioLabs, Inc. (CBLI), a Nasdaq-listed biotechnology company, in a reverse merger that takes the private company public. The deal was announced on Oct 19, 2020 and closed on Jul 28, 2021. The combined company trades as Cytocom, Inc. (CBLI) on Nasdaq.
Cytocom, Inc. (later Statera Biopharma) is a biopharmaceutical company creating therapies focused on immune homeostasis, formed when private Cytocom merged into Cleveland BioLabs.
- Status
- Completed
- Private company
- Cytocom Inc.
- Public company
- Cleveland BioLabs, Inc. (CBLI)
- Public company business before
- Nasdaq-listed biotechnology company
- Announced
- Oct 19, 2020
- Closed
- Jul 28, 2021
- Combined company
- Cytocom, Inc. (CBLI)
- Exchange
- Nasdaq
- Sector
- Biotech & pharma
More on this deal for subscribers
- Ownership split between private and public holders
- Analyst notes from the filings
Every record in the database also has its full filing timeline, a daily-updated calendar, watchlist alerts and Excel export.
Then $99/month or $999/year. Cancel anytime.
Filings
- Closing 8-K Jul 28, 2021
- Closing press release / exhibit
- All filings on EDGAR CIK 1318641
Other completed reverse mergers
- Stemtech Corporationinto Globe Net Wireless Corp. · Aug 19, 2021
- Tingo Mobile PLCinto IWEB, Inc. · Aug 15, 2021
- HyEdge, Inc.into FICAAR, Inc. · Aug 11, 2021
- Decoy Biosystems, Inc.into Intec Pharma Ltd. (via Intec Parent, Inc.) · Aug 3, 2021
- Stagwell Media LP (Stagwell Marketing Group)into MDC Partners Inc. · Aug 2, 2021
- Krypto Ventures, Inc.into W Technologies, Inc. · Jul 29, 2021